GH Research (GHRS.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov7

GH Research released FY2025 Q3 earnings on November 6 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.226 (forecast USD -0.235)

04:00

GH Research released FY2025 9 Months earnings on November 6 (EST), actual revenue USD 0, actual EPS USD -0.562

04:00

Nov6

GH Research plc updates its clinical pipeline, showing significant results for candidate drug GH001 in Phase 2b trials

12:09

Oct17

GH Research plc Announces Clinical Trial Results for GH001 in Treatment of Treatment-Resistant Depression

11:03

Oct13

Needham Gives GH Research PLC Drug GH-001 a Buy Rating

18:17

Oct9

GH Research PLC Accepts Invitation to New Therapy Workshop

12:10

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -14.02 M, EPS -0.226

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -9.289 M, EPS -0.1497

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -10.81 M, EPS -0.1863

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More